Addisonian syndrome associated with treosulfan.
D000224:Addison Disease / Q000139:chemically induced*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002066:Busulfan / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans
D000970:Antineoplastic Agents; D002066:Busulfan